These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3214462)

  • 21. The 4S study: a critical review.
    Pauciullo P
    Pharmacol Res; 1997 Mar; 35(3):165-6. PubMed ID: 9229401
    [No Abstract]   [Full Text] [Related]  

  • 22. Beneficial effects of statins.
    Rosenson RS; Tangney CC
    Lancet; 1996 Dec; 348(9041):1583. PubMed ID: 8950893
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor.
    Thiery J; Armstrong VW; Schleef J; Creutzfeldt C; Creutzfeldt W; Seidel D
    Klin Wochenschr; 1988 May; 66(10):462-3. PubMed ID: 2969433
    [No Abstract]   [Full Text] [Related]  

  • 24. The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia.
    Prihoda JS; Pappu AS; Smith FE; Illingworth DR
    J Clin Endocrinol Metab; 1991 Mar; 72(3):567-74. PubMed ID: 1847705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
    Serajuddin AT; Ranadive SA; Mahoney EM
    J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
    Castelao AM; Griñó JM; Andrés E; Gilvernet S; Serón D; Castiñeiras MJ; Roca M; Galcerán JM; González MT; Alsina J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1043-6. PubMed ID: 8442035
    [No Abstract]   [Full Text] [Related]  

  • 27. Statins do more than just lower cholesterol.
    Vaughan CJ; Murphy MB; Buckley BM
    Lancet; 1996 Oct; 348(9034):1079-82. PubMed ID: 8874463
    [No Abstract]   [Full Text] [Related]  

  • 28. Lovastatin, pravastatin, and serum lipoprotein(a).
    Jacob BG; Richter WO; Schwandt P
    Ann Intern Med; 1990 May; 112(9):713-4. PubMed ID: 2139768
    [No Abstract]   [Full Text] [Related]  

  • 29. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
    Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia.
    Zhao SP; Hollaar L; van 't Hooft FM; Smelt AH; Gevers Leuven JA; van der Laarse A
    Clin Chim Acta; 1991 Dec; 203(2-3):109-17. PubMed ID: 1777975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is a statin a statin?
    Wierzbicki AS
    Int J Clin Pract; 2001 Mar; 55(2):79-80. PubMed ID: 11321864
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
    Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
    Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effect of simvastatin on lipoprotein cholesteryl ester metabolism in normocholesterolemic volunteers.
    Magot T; Malmendier CL; Ouguerram K; Lontie JF; Lutton C
    Clin Chim Acta; 1991 Jan; 196(1):59-68. PubMed ID: 2022059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia.
    Cucuianu M; Popescu TA; Opincaru A; Hărăgus S
    Clin Chim Acta; 1975 Feb; 59(1):19-27. PubMed ID: 164306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H; Fujiya S; Aanuma Y; Agishi Y
    Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of lovastatin, simvastatin, and pravastatin on sterol synthesis and their antiproliferative effect in cultured myoblasts from human striated muscle.
    van Vliet AK; Nègre-Aminou P; van Thiel GC; Bolhuis PA; Cohen LH
    Biochem Pharmacol; 1996 Nov; 52(9):1387-92. PubMed ID: 8937448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs.
    Matsunaga A; Sasaki J; Takada Y; Hidaka K; Arakawa K
    Atherosclerosis; 1991 Sep; 90(1):31-7. PubMed ID: 1665974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein(a) and ischaemic heart disease.
    Jones AF; Lemon M; Bain SC; Walker MR
    Lancet; 1990 Sep; 336(8718):813-4. PubMed ID: 1976174
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of hypercholesterolaemia, simvastatin and dietary fat on the low density lipoprotein receptor of unstimulated mononuclear cells.
    Roach PD; Hosking J; Clifton PM; Bais R; Kusenic B; Coyle P; Wight MB; Thomas DW; Nestel PJ
    Atherosclerosis; 1993 Nov; 103(2):245-54. PubMed ID: 8292099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The mechanism of action of hypolipidemic drugs].
    Scheen AJ
    Rev Med Liege; 1997 Jun; 52(6):445-6. PubMed ID: 9289779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.